Home > Insider Trading > Filing (0001181431-11-025558)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
820096	Perrigo Co	PRGO	Pharmaceutical Preparations (2834)	382799573

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1242215	C Joseph Papa	C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010	President And Ceo	Yes	Yes	No	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2011-04-25	15,000	$20.50	124,337	No	4	M	Direct
Common Stock	Disposition	2011-04-25	20,800	$88.50	103,537	No	4	S	Direct
Common Stock	Disposition	2011-04-25	200	$89.12	103,337	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option Right to Buy	Disposition	2011-04-25	8,977	$0.00	8,977	$20.50
Common Stock	Employee Stock Option Right to Buy	Disposition	2011-04-25	6,023	$0.00	20,806	$20.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2008-08-30	2017-08-30	No	4	M	Direct
14,783	2009-08-30	2017-08-30	No	4	M	Direct

Footnotes

A Rule 10b5-1 sales plan adopted by the reporting person on February 7, 2011, is scheduled to sell shares on February 22, 2011, March 22, 2011 and April 25, 2011. This 10b5-1 sales plan will expire on the close of business on April 25, 2011.
The price in column 4 is a weighted average. The prices actually recieved ranged from $88.00 to $89.00. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each seperate price within the range.